Artificial Intelligence (AI) in Pharmacovigilance Global Market Report 2026 | Capitalize on 19.6% CAGR to 2030 as Oracle, Microsoft, Google and IQVIA Accelerate Automation

Company Logo Boost ROI by automating safety workflows, integrating multisource data, improving signal detection, and retaining human oversight for compliance. Dublin, Oct. 27, 2026 (GLOBE NEWSWIRE) -- "Artificial Intelligence (AI) in Pharmacovigilance Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global artificial intelligence (AI) in pharmacovigilance market is experiencing rapid growth as pharmaceutical companies, healthcare organizations and regulators adopt advanced technologies to strengthen drug safety monitoring. The market is projected to increase from $0.77 billion in 2025 to $0.92 billion in 2026, representing a compound annual growth rate (CAGR) of 19.3%.